Showing results (121-130 of 501) with videos related to

Sort By:
Pageof 51
International Journal of Radiation Oncology, Biology, Physics|October 18, 2007
Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiencesAvraham Eisbruch, Peter C Levendag, Felix Y Feng, et al.
Cancer|August 16, 2012
The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancerMark Shilkrut, Gregory S Merrick, P William McLaughlin, et al.
Hepatology (Baltimore, Md.)|November 2, 2017
Combinatorial genetics in liver repopulation and carcinogenesis with a in vivo CRISPR activation platformKirk J Wangensteen, Yue J Wang, Zhixun Dou, et al.
Head & Neck|October 9, 2015
Maintaining physical activity during head and neck cancer treatment: Results of a pilot controlled trialShuang G Zhao, Neil B Alexander, Zora Djuric, et al.
European Urology|March 31, 2021
Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate CancerAnbarasu Kumaraswamy, Katherine R Welker Leng, Thomas C Westbrook, et al.
Scientific Reports|September 28, 2020
SV-HotSpot: detection and visualization of hotspots targeted by structural variants associated with gene expressionAbdallah M Eteleeb, David A Quigley, Shuang G Zhao, et al.
Neoplasia (New York, N.Y.)|July 9, 2015
Platelet-Synthesized Testosterone in Men with Prostate Cancer Induces Androgen Receptor SignalingAlexander B Zaslavsky, Audrey Gloeckner-Kalousek, Mackenzie Adams, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 6, 2021
A bicentric retrospective analysis of clinical utility of <sup>18</sup>F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria?Ali Salavati, Mehmet Gencturk, Yasemin Koksel, et al.
International Journal of Radiation Oncology, Biology, Physics|October 9, 2012
Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: prospective study of patient-reported, observer-rated, and objective outcomesKlaudia U Hunter, Matthew Schipper, Felix Y Feng, et al.
Elife|November 16, 2022
The <i>CIC-ERF</i> co-deletion underlies fusion-independent activation of ETS family member, ETV1, to drive prostate cancer progressionNehal Gupta, Hanbing Song, Wei Wu, et al.
Pageof 51